Skip to main content
. 2019 Sep 10;9:13014. doi: 10.1038/s41598-019-49484-4

Figure 4.

Figure 4

Palbociclib combined with paclitaxel induces different effects on cell death depending on the treatment schedule. TNBC cell lines were incubated for 48 h with 0.5 µM palbociclib and 10 nM paclitaxel, alone or simultaneously combined (Palb + PTX), or were treated with palbociclib for 24 h and then with paclitaxel for further 48 h (Palb → PTX). Cell viability (a,b) and cell death (c,d) were assessed by counting the cells in a Bürker hemocytometer with the trypan blue exclusion method and by fluorescence microscopy after Hoechst 33342/PI staining, respectively. **p < 0.01, ***p < 0.001 vs C; ###p < 0.001 vs PTX; §p < 0.05, §§§p < 0.001 vs Palb + PTX. (e,f) PARP-1 cleavage was detected by Western blotting. Data in (ad) are mean values ± SD of three independent experiments. Results in (e and f) are representative of two independent experiments.